NCT04436432

Brief Summary

This study investigates the prevalence, phenomenology, and correlates of anxiety in preschool children with autism spectrum disorder (ASD) across a two-year period. Attention bias to threat, a potential objective marker of anxiety, also is examined using eye tracking methods.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 25, 2018

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

June 4, 2020

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 18, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2021

Completed
Last Updated

November 24, 2021

Status Verified

November 1, 2021

Enrollment Period

2.7 years

First QC Date

June 4, 2020

Last Update Submit

November 23, 2021

Conditions

Keywords

AutismAnxietyEye trackingPreschool

Outcome Measures

Primary Outcomes (2)

  • Anxiety diagnostic status as measured by Anxiety Disorders Interview Schedule with Autism Addendum

    Gold-standard semi-structured interview for assessing anxiety disorders and the ASA, a supplement to the ADIS that facilitates the use of this tool in children with ASD; clinical severity ratings range from 0 to 3 or 0 to 8; higher scores indicate more impairment

    Anxiety diagnostic status will be measured through study completion, up to 24 months

  • Attention to threat behavioral paradigms

    Child's attention to threatening stimuli measured via eye tracking and correlated physiological response measures via pupillometry; more frequent saccades to threatening stimuli indicate higher attention bias to threat; greater pupil dilation indicates higher physiological arousal

    Attention to threat and correlated physiological arousal will be measured across the final 12 months of the study

Secondary Outcomes (12)

  • Child Behavior Checklist

    Anxiety and other psychiatric symptoms will be assessed through study completion, up to 24 months

  • Preschool Anxiety Scale - Revised

    Anxiety will be assessed through study completion, up to 24 months

  • Screen for Child Anxiety Related Disorders

    Anxiety will be assessed through study completion, up to 24 months

  • Response to Uncertainty and Low Environmental Stability Scale

    Intolerance of uncertainty will be assessed through study completion, up to 24 months

  • Social Responsiveness Scale

    ASD symptoms will be assessed through study completion, up to 24 months

  • +7 more secondary outcomes

Study Arms (1)

Assessment

Children with ASD ages 3-5 years at baseline

Eligibility Criteria

Age36 Months - 71 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Clinical and community based sample

You may qualify if:

  • Age 3 years 0 months to 5 years 11 months;
  • DSM-5 ASD diagnosis based on clinical impressions and results of the Autism Diagnostic Observation Schedule-2 (ADOS-2)
  • Child resides with at least one biological parent
  • Parents are English speaking

You may not qualify if:

  • History of psychological trauma
  • History of neurologic illness
  • Parent substance abuse, bipolar disorder, psychosis
  • Parents require support from a medical interpreter
  • Child displays severe behavior challenges
  • Severe eyesight or hearing impairments that may interfere with the protocols

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kennedy Krieger Institute

Baltimore, Maryland, 21211, United States

Location

Related Publications (2)

  • Vasa RA, Kreiser NL, Keefer A, Singh V, Mostofsky SH. Relationships between autism spectrum disorder and intolerance of uncertainty. Autism Res. 2018 Apr;11(4):636-644. doi: 10.1002/aur.1916. Epub 2018 Jan 7.

    PMID: 29316350BACKGROUND
  • Vasa RA, Keefer A, Reaven J, South M, White SW. Priorities for Advancing Research on Youth with Autism Spectrum Disorder and Co-occurring Anxiety. J Autism Dev Disord. 2018 Mar;48(3):925-934. doi: 10.1007/s10803-017-3320-0.

    PMID: 29164436BACKGROUND

Related Links

MeSH Terms

Conditions

Anxiety DisordersAutism Spectrum DisorderAutistic Disorder

Condition Hierarchy (Ancestors)

Mental DisordersChild Development Disorders, PervasiveNeurodevelopmental Disorders

Study Officials

  • Roma A Vasa, M.D.

    Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Psychiatric Services

Study Record Dates

First Submitted

June 4, 2020

First Posted

June 18, 2020

Study Start

October 25, 2018

Primary Completion

July 1, 2021

Study Completion

July 1, 2021

Last Updated

November 24, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations